From Vaccines to Vision: Unlocking mRNA’s Next Clinical Success
- Learning from vaccines: Exploring how mRNA’s transient biology is not a drawback but an asset
- Building on innovation: Reviewing how advances in mRNA topologies, stability, and delivery systems are expanding what mRNA can achieve
- Why Ophthalmology?: Discussing how eye diseases demand localized, adjustable, and repeatable therapies, exactly where transient, programmable mRNA expression can deliver disease-modifying therapies or cures